Through comprehensively integrating two‐stage population survival analysis and multipronged biochemical experiments in this study, we identified a germline variant rs2274110 in MCM10 that confers an inferior survival of ESCC patients. This evidence concerns the gene MCM10 and esophageal squamous cell carcinoma.